X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pharmacology & pharmacy (20) 20
cyp3a4-asterisk-22 (16) 16
index medicus (16) 16
pharmacokinetics (15) 15
humans (14) 14
cytochrome p-450 cyp3a - genetics (13) 13
female (13) 13
genotype (12) 12
male (11) 11
pharmacogenetics (9) 9
adult (8) 8
middle aged (8) 8
tacrolimus (8) 8
tacrolimus - pharmacokinetics (7) 7
cytochrome p-450 (6) 6
immunosuppressive agents - pharmacokinetics (6) 6
polymorphisms (6) 6
cytochrome p-450 cyp3a - metabolism (5) 5
impact (5) 5
polymorphism (5) 5
polymorphism, single nucleotide (5) 5
retrospective studies (5) 5
aged (4) 4
cyp3a4-asterisk-22 polymorphism (4) 4
cyp3a5 (4) 4
cytochrome (4) 4
dose requirements (4) 4
drug metabolism (4) 4
genetic aspects (4) 4
immunosuppressive agents - therapeutic use (4) 4
in-vitro (4) 4
kidney transplantation (4) 4
metabolism (4) 4
tacrolimus - therapeutic use (4) 4
toxicology (4) 4
transplant recipients (4) 4
transplantation (4) 4
transplants & implants (4) 4
young adult (4) 4
abcb1 (3) 3
alleles (3) 3
calcineurin inhibitors (3) 3
cyclosporine (3) 3
cyp3a4 (3) 3
genotype & phenotype (3) 3
graft rejection - genetics (3) 3
health aspects (3) 3
kidney transplantation - methods (3) 3
kidneys (3) 3
medical laboratory technology (3) 3
phenotype (3) 3
por (3) 3
research (3) 3
tacrolimus - administration & dosage (3) 3
abridged index medicus (2) 2
adolescent (2) 2
allele (2) 2
antipsychotic agents - pharmacokinetics (2) 2
antipsychotics (2) 2
aripiprazole (2) 2
association (2) 2
breast cancer (2) 2
breast neoplasms - drug therapy (2) 2
cross-sectional studies (2) 2
cyp3a (2) 2
cytochrome p-450 cyp2d6 - genetics (2) 2
cytochrome p-450 enzyme system - genetics (2) 2
cytochrome p450 (2) 2
dose-response relationship, drug (2) 2
drug interactions (2) 2
drug-related side effects and adverse reactions - genetics (2) 2
enzymes (2) 2
expression (2) 2
genes (2) 2
graft rejection - metabolism (2) 2
graft rejection - prevention & control (2) 2
identification (2) 2
immunosuppressive agents - administration & dosage (2) 2
leukemia (2) 2
nadph-ferrihemoprotein reductase - genetics (2) 2
organ transplant recipients (2) 2
patient outcomes (2) 2
pharmacodynamics (2) 2
pharmacogenomic variants (2) 2
pharmacology (2) 2
pharmacology/toxicology (2) 2
physiological aspects (2) 2
plasma (2) 2
polymorphism, single nucleotide - genetics (2) 2
population pharmacokinetics (2) 2
ppar alpha - genetics (2) 2
renal transplantation (2) 2
renal-transplantation (2) 2
risk factors (2) 2
safety (2) 2
single-nucleotide polymorphisms (2) 2
tissue donors (2) 2
trough blood-levels (2) 2
variant (2) 2
2nd-generation antipsychotics (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PHARMACOGENETICS AND GENOMICS, ISSN 1744-6872, 01/2016, Volume 26, Issue 1, pp. 40 - 43
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 09/2019, Volume 106, Issue 3, pp. 585 - 595
In addition to the effect of cytochrome P450 ( CYP ) 2D6 genetic polymorphisms, the metabolism of tamoxifen may be impacted by other factors with possible... 
WOMEN | CYP3A4-ASTERISK-22 | CONSORTIUM CPIC GUIDELINE | POLYMORPHISMS | ACTIVITY SCORE | PHARMACOLOGY & PHARMACY | PHARMACOGENETICS | VITAMIN-D STATUS | CYP2D6 GENOTYPE | CYP3A4 | ESTROGEN-RECEPTOR | Index Medicus | Abridged Index Medicus
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 5/2019, Volume 58, Issue 5, pp. 651 - 658
As pazopanib plasma trough concentrations are correlated with treatment outcome, we explored whether single nucleotide polymorphisms in the elimination pathway... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | ALLELE | T POLYMORPHISM CYP3A4-ASTERISK-22 | GENOTYPE | SAFETY | GENES | PHARMACOLOGY & PHARMACY | PHASE-I | VARIANT | RENAL-CELL CARCINOMA | EXPOSURE | Cytochrome | Studies | Enzymes | Transplants & implants | Leukemia | Kidney cancer | Metabolism | Drug dosages | Polymorphism | Original
Journal Article
Pharmacology, ISSN 0031-7012, 06/2019, Volume 104, Issue 1-2, pp. 43 - 50
Background/Aims: Extrapyramidal symptoms (EPS) are representative side effects of antipsychotics, caused by their inhibitory action on dopaminergic nerves in... 
Brief Report | Antipsychotics | Extrapyramidal symptoms | Recombinant human acetylcholinesterase | Aripiprazole | SCHIZOPHRENIA | RISPERIDONE | ANTI-ALZHEIMER | PHARMACOKINETICS | METABOLISM | PHARMACOLOGY & PHARMACY | CYP3A4-ASTERISK-22 POLYMORPHISM | RECEPTORS | BINDING
Journal Article
Journal of Pharmacological Sciences, ISSN 1347-8613, 06/2019, Volume 140, Issue 2, pp. 197 - 200
Antipsychotics are often the first-line treatment for behavioral and psychological symptoms of dementia. However, the potential anticholinergic effects of... 
Antipsychotics | Anticholinergic effect | Mouse cerebral cortex | PLASMA | RAT | DRUGS | PHARMACOLOGY & PHARMACY | CYP3A4-ASTERISK-22 POLYMORPHISM | Cerebral cortex | Pharmacology, Experimental | Antipsychotic drugs | Enzyme inhibitors | Cholinesterases | Physiological aspects | Models | Research | Chemical properties | Pharmacokinetics | Health aspects | Index Medicus
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 6/2014, Volume 70, Issue 6, pp. 685 - 693
Tacrolimus (Tac) and cyclosporine (CsA) are mainly metabolized by CYP3A4 and CYP3A5. Several studies have demonstrated an association between the CYP3A5... 
CYP3A | POR | Biomedicine | Calcineurin inhibitors | Kidney recipients | Pharmacology/Toxicology | Pharmacokinetics | PPARA | CYP3A4-ASTERISK-22 | GENOTYPE | POLYMORPHISM | CLINICAL PHARMACOKINETICS | DOSE REQUIREMENTS | CYTOCHROME-P450 OXIDOREDUCTASE | IN-VITRO | P450 OXIDOREDUCTASE | IMPACT | PHARMACOLOGY & PHARMACY | MIDAZOLAM | NADPH-Ferrihemoprotein Reductase - genetics | Humans | Immunosuppressive Agents - pharmacokinetics | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Cyclosporine - blood | Dose-Response Relationship, Drug | Young Adult | Immunosuppressive Agents - blood | Cytochrome P-450 CYP3A - genetics | Cyclosporine - pharmacokinetics | Adult | Female | Retrospective Studies | Real-Time Polymerase Chain Reaction | Immunosuppressive Agents - administration & dosage | Tacrolimus - administration & dosage | Tacrolimus - blood | Gene Frequency | Genotype | PPAR alpha - genetics | Kidney Transplantation | Tacrolimus - pharmacokinetics | Cyclosporine - therapeutic use | Tacrolimus - therapeutic use | Analysis of Variance | Polymorphism, Restriction Fragment Length | Cyclosporine - administration & dosage | Aged | Kidneys | Tacrolimus | Cytochrome P-450 | Genetic research | Physiological aspects | Drugstores | Organ transplant recipients | Transplantation | Cyclosporine | Genetics | Pharmacology | Transplants & implants | Index Medicus | Pharmacogenetics
Journal Article
Journal Article
Basic & Clinical Pharmacology & Toxicology, ISSN 1742-7835, 06/2018, Volume 122, Issue 6, pp. 596 - 605
Journal Article
THERAPEUTIC DRUG MONITORING, ISSN 0163-4356, 04/2016, Volume 38, Issue 2, pp. 223 - 229
Journal Article
International Journal of Neuropsychopharmacology, ISSN 1461-1457, 2016, Volume 19, Issue 12
Journal Article
Therapeutic Drug Monitoring, ISSN 0163-4356, 2015, Volume 37, Issue 6, pp. 733 - 744
Journal Article
Journal Article